Back to KROS

GEODE CAPITAL MANAGEMENT, LLC → KROS

GEODE CAPITAL MANAGEMENT, LLC KROS Position History

Keros Therapeutics, Inc. • Healthcare

Quarters held
10
Latest value
$879K
Q3 2026
Peak value
$11.6M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$11.6M
Q3 2025$1.7M
Q4 2025$11.4M
Q4 2025$1.6M
Q1 2026$6.6M
Q1 2026$907K
Q2 2026$4.7M
Q2 2026$773K
Q3 2026$4.8M
Q3 2026$879K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$879K77.1K——
Q3 2026$4.8M419.1K——
Q2 2026$773K72.3K——
Q2 2026$4.7M438.6K——
Q1 2026$907K82.2K——
Q1 2026$6.6M599.3K——
Q4 2025$1.6M77.7K——
Q4 2025$11.4M557.5K——
Q3 2025$1.7M105.4K——
Q3 2025$11.6M731.9K——

Other funds holding KROS

$288.7M
$240.4M
$182.8M
$175.4M
$171.8M
$163.6M
$161.9M
$144.3M

Other GEODE CAPITAL MANAGEMENT, LLC positions

NVDA

NVIDIA CORP

$122B
AAPL

APPLE INC

$108.8B
NVDA

NVIDIA CORP

$105.6B
NVDA

NVIDIA CORP

$96.7B
NVDA

NVIDIA CORP

$96.6B
AAPL

APPLE INC

$93.5B
NVDA

NVIDIA CORP

$91.6B
MSFT

MICROSOFT CORP

$86B